Q3 Earnings Alert! Plan early for this week’s stock reports with all key data in 1 placeSee list

Mind Medicine Inc (MNMD)

NASDAQ
Currency in USD
Disclaimer
5.410
+0.240(+4.64%)
Closed
After Hours
5.490+0.080(+1.479%)
MNMD Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Fair Value
Day's Range
5.0335.440
52 wk Range
2.41012.220
Prev. Close
5.17
Open
5.16
Day's Range
5.033-5.44
52 wk Range
2.41-12.22
Volume
605,090
Average Vol. (3m)
863,801
1-Year Change
98.17%
Book Value / Share
Unlock
Fair Value
Unlock
Fair Value Upside
Unlock
MNMD Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
26.250
Upside
+385.213%
Members' Sentiments
Bearish
Bullish
ProTips
4 analysts have revised their earnings upwards for the upcoming period
Show more

InvestingPro Research for Mind Medicine Inc


Analyst Optimism
Price targets range from $22 to $36, reflecting confidence in MM120's potential. However, current trading remains in the $8-$9 range as of mid-2024.
Market Potential
Analysts project MM120 could reach $2.29 billion in revenue by 2031, tapping into a multi-billion-dollar market for anxiety treatment.
Clinical Success
Phase 2b trials reveal MM120's significant anxiety reduction, rapid onset, and sustained effects for up to 12 weeks, outperforming current therapies.
Breakthrough Anxiety Treatment
MindMed's MM120, an LSD-based compound, shows promise in treating generalized anxiety disorder with a single dose, potentially revolutionizing mental health care.

Mind Medicine Inc Company Profile

Mind Medicine (MindMed) Inc., a clinical stage biopharmaceutical company, develops novel products to treat brain health disorders. The company’s lead product candidates include MM-120, which is in phase 2 for the treatment of generalized anxiety disorder and attention deficit hyperactivity disorder; and MM-402, a R-enantiomer of 3,4-methylenedioxymethamphetamine, which is in phase I clinical trials for the treatment of core symptoms of autism spectrum disorder. Mind Medicine (MindMed) Inc. is headquartered in New York, New York.

Compare MNMD to Peers and Sector

Metrics to compare
MNMD
Peers
Sector
Relationship
P/E Ratio
−4.3x−0.8x−0.6x
PEG Ratio
−1.610.000.00
Price / Book
2.2x0.8x2.6x
Price / LTM Sales
-2.7x3.2x
Upside (Analyst Target)
286.8%61.2%43.9%
Fair Value Upside
Unlock15.8%7.8%Unlock

People Also Watch

4.3300
GERN
0.00%
1.240
SLS
+3.33%
40.68
CRTO
+0.99%
10.35
ALMS
+0.58%
46.98
GLP
-0.34%

FAQ

What Is the Mind Medicine (MNMD) Stock Price Today?

The Mind Medicine stock price today is 5.41

What Stock Exchange Does Mind Medicine Trade On?

Mind Medicine is listed and trades on the NASDAQ stock exchange.

What Is the Stock Symbol for Mind Medicine?

The stock symbol for Mind Medicine is "MNMD."

What Is the Mind Medicine Market Cap?

As of today, Mind Medicine market cap is 440.54M.

What is Mind Medicine Earnings Per Share?

The Mind Medicine EPS is -2.04.

What Is the Next Mind Medicine Earnings Date?

Mind Medicine will release its next earnings report on Apr 08, 2025.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.